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Postoperative cognitive dysfunction, a subtle deteriora-
tion of cognitive function after exposure to anesthetics, 
is reported in 10% to 50% of surgical cases. Delivery 
of excessive inhalation anesthetics based on minimum 
alveolar concentration produces greater deep hypnotic 
times, which may contribute to postoperative cognitive 
dysfunction. This study tested the impact on cognitive 
function of balanced anesthetic using electroencephalo-
graphic (EEG) guidance vs usual anesthesia. We studied 
88 surgical patients: 45 randomly assigned to balanced 
anesthetic technique with EEG guidance and 43 to stan-
dard treatment. Cognitive function was evaluated with 
the Cambridge Neuropsychological Test Automated 
Battery-Mild Cognitive Impairment at 3 intervals (pre-
operatively, 3-5 days postoperatively, and 3-5 months 
postoperatively). Additionally, 37 age- and sex-matched 
individuals not undergoing surgery or anesthesia were 
evaluated at the same intervals. Better outcomes were 
seen in the intervention group compared with usual care 
in the short-term/visual memory cognitive domain (P = 
.02) at 3 to 5 days, but not at 3 to 5 months. Delivery of 
anesthesia using EEG monitoring systems can reduce 
cumulative deep hypnotic time without negatively affect-
ing patient physiologic stress, surgical conditions, or 
cognitive function. Our findings provide data to support 
optimal anesthetic approaches to improve cognitive 
function after anesthesia with volatile anesthetics.
Keywords: Anesthesia technique, mild cognitive 
impairment, postoperative cognitive dysfunction.
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P
ostoperative cognitive dysfunction (POCD) 
is a subtle deterioration of cognitive function 
observed after surgical procedures with anes-
thetics. In POCD, deficits in advanced cognitive 
function and memory continue after appropriate 
anesthetic drug half-lives have expired.1 The incidence of 
POCD ranges from 10% to 50% depending on definitions, 
study designs, sample sizes, and neurocognitive measures 
used.2,3 This cognitive decline is associated with increased 
1-year mortality as well as morbidity and family/caregiver 
stress.4 Socially, these deficits also lead to earlier retirement 
and greater reliance on social financial support systems.5
Inhalation anesthetics have neuropathogenic effects 
similar to the changes seen in dementias, including 
Alzheimer disease (AD).6-9 Mild cognitive impairment 
(MCI) is a prodromal classification of the dementias, af-
fecting cognitive domains similarly to POCD.10 Based on
the known properties of inhalation anesthetics, research-
ers have suggested that anesthetic techniques with greater
cumulative deep hypnotic time result in a greater degree of
POCD.11,12 It is possible to decrease cumulative deep hyp-
notic time by using derived electroencephalographic (EEG) 
monitoring to titrate volatile anesthetics, but this method 
is not yet standard therapy.11,12 One of the major modali-
ties for delivering EEG-guided anesthesia is the Bispectral 
Index (BIS, Covidien, now Medtronic). To provide rigor-
ous data on the neurocognitive outcomes associated with 
BIS-guided anesthesia, we conducted a randomized con-
trolled trial of BIS-guided anesthesia vs standard anesthesia 
care using concentration-guided techniques. 
The aim of this study was to determine the impact of 
BIS-guided anesthesia vs standard anesthesia care on neu-
rocognitive scores from preoperative baseline, 3 to 5 days 
postoperatively, and 3 to 5 months postoperatively between 
individuals undergoing anesthetic for surgical procedures 
lasting longer than 2 hours. We hypothesized that BIS-
guided anesthesia compared with standard anesthesia care 
will result in less postoperative cognitive impairment.
Methods
• Design. This study was a prospective, randomized con-
trolled trial. Parallel study groups underwent anesthesia
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for select surgical procedures. Study participants (N = 
88) were randomly assigned to BIS-guided anesthesia
(group 1, n = 45) or standard anesthesia care (group 2,
n = 43). The standard anesthesia care group underwent
anesthesia with inhalation anesthetics titrated around
minimum alveolar concentration (MAC) values. Patients
in the BIS-guided anesthesia group underwent titra-
tion using BIS. We used BIS in a tight reference range
to avoid deep anesthesia (ie, BIS < 40) by maintaining
a BIS range of 45 to 60. Participants completed the
Cambridge Neuropsychological Test Automated Battery–
Mild Cognitive Impairment (CANTAB-MCI) at 3 inter-
vals: preoperatively, at 3 to 5 days postoperatively, and
at 3 to 5 months postoperatively. This state-of-the-art,
highly sensitive neurocognitive testing system is easy for
patients of all ages to use and has been shown to obtain
valid and reproducible outcomes.13-16
• Sample and Setting. Patients aged 45 to 70 years un-
dergoing general anesthesia for an elective surgical proce-
dure scheduled to last approximately 2 hours at an academ-
ic medical center who met selection criteria and agreed to 
participate were eligible for enrollment. After baseline data 
collection, computer randomization was used to randomly 
assign patients to receive general anesthesia with either BIS-
guided anesthesia or standard anesthesia care.
Inclusion criteria for participants was assessment as 
ASA classes 1 through 4 and scheduled for surgeries 
requiring general endotracheal anesthesia with a neu-
romuscular paralytic agent. Only participants success-
fully completing the Motor Screening Task test from the 
CANTAB-MCI were invited to participate in the study.
We excluded individuals with substantial cardio-
respiratory or other end-organ disease (ie, unstable 
angina, uncontrolled diabetes, severe peripheral vascular 
disease), inadequate English, and/or substance abuse. We 
also excluded individuals with preexisting neurologic 
diseases as well as neurosurgical candidates. These exclu-
sion criteria were chosen because these types of patients 
have a known high potential for cognitive impairment 
unrelated to POCD or for postoperative complications 
that introduce potential confounders.
Patients were referred to the study by physicians and/
or nurse practitioners working in the Preoperative Clinic 
and by surgeons in the medical center. Study staff recruit-
ed individuals who fit the inclusion and exclusion crite-
ria after completing a preoperative screening interview. 
• Intervention. Anesthetic technique for both surgi-
cal groups included standard induction with available 
agents, neuromuscular paralysis guided by a nerve stimu-
lator, inhalation anesthetic, and intraoperative monitor-
ing in accordance with the guidelines of the medical 
center’s Department of Anesthesiology and the ASA. 
Invasive monitoring, including arterial pressure, and 
central venous pressure was performed at the discretion 
of the anesthesia provider.
The BIS monitors were applied to both groups. The 
anesthesia provider for patients in the standard anesthe-
sia care group did not see the BIS values. Titration and 
administration of anesthesia were performed according 
to standard clinical practice. In the BIS-guided anesthesia 
group, the anesthesia provider titrated the volatile anes-
thetic to maintain a BIS range of 45 to 60, but not less 
than 0.5 age-adjusted MAC, as measured by the Apollo 
anesthesia machine version 4.1 (Draeger).
Physicians and nurse anesthetists who volunteered 
for the study underwent a well-defined training period 
and used well-defined anesthetic plans. Data were 
collected from the anesthetic record after each case. 
Intraoperatively, anesthesia clinicians could have aborted 
the study protocol as they deemed necessary for partici-
pant stability and safety, but this never occurred.
Measures
• Demographic and Clinical Data. The following patient
demographic variables were collected by an interview-
based questionnaire: age, sex, race/ethnicity, marital
status and whether the patient lives alone, education
level, and annual income.
The ASA classification, previous anesthetics, current 
medication regimen, drugs used during surgery, physi-
cal examination findings, total intraoperative anesthetic 
time, perioperative narcotic exposure, and comorbidities 
were obtained from the anesthetic record. Inhalation 
anesthetic type as well as inspired and expired concentra-
tions were recorded, as were BIS scores.
• Neurocognitive Testing. The CANTAB-MCI system
was used to measure cognitive function and is a com-
puterized, touch screen–based group of 5 tests. The 
CANTAB-MCI battery includes the Motor Screening 
Task, Delayed Matching to Sample, Rapid Visual 
Information Processing, Paired Associates Learning, and 
Reaction Time. Tests are scored by the number of correct 
responses and/or time to complete the task as appropri-
ate. The Motor Screening Task (2 minutes) is a simple 
introduction to the touch screen. This task functions as a 
screening test for visual, movement, and comprehension 
difficulties. Inability of the subject to complete the Motor 
Screening Task rendered that person ineligible for use of 
the CANTAB-MCI. None of our patients were excluded 
based on the Motor Screening Task result. 
The CANTAB-MCI was used to measure cognitive 
function in 4 domains: memory, attention, short-term/
visual memory, and speed of processing. 
• Memory Domain. The Delayed Matching to Sample
(10 minutes) was used to assess cognition in the memory 
domain for nonverbalizable patterns, testing both simul-
taneous and short-term visual memory domains. Our 
outcome measure was the Delayed Matching to Sample 
percent correct. 
• Attention Domain. Testing with the Rapid Visual
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Information Processing (7 minutes) sustained attention by 
assessing ability to recall a sequence of digits. Inability to 
sustain attention is a characteristic of delirium; thus, this 
measure assists in the differentiation of dementia or MCI 
from delirium. The Rapid Visual Information Processing 
is sensitive for the visual sustained attention domain. We 
used 2 outcome measures to reflect this domain: Rapid 
Visual Information Processing A′ (A prime) and Rapid 
Visual Information Processing median latency. 
• Short-Term/Visual Memory Domain. The Paired
Associates Learning (10 minutes) was used to assess the 
short-term/visual memory domain. The Paired Associates 
Learning is useful for assessing individuals with question-
able dementia, MCI, AD, and age-related memory loss. 
Patients are asked to associate visual patterns that cannot 
be verbalized with spatial locations on the computer screen. 
We used 2 outcome measures to reflect this domain: Paired 
Associates Learning total errors 6 shapes adjusted and 
Paired Associates Learning total errors adjusted. 
• Speed of Processing Domain. The final domain test is
the Reaction Time (5 minutes). The Reaction Time is a 
speed of processing/latency domain task with a compara-
tive history (the 5-choice task) and uses a procedure to 
separate response latency from movement time. This 
allows for control for participants with tremor. We used 
4 outcome measures to reflect this domain. The Reaction 
Time mean simple reaction time and the Reaction Time 
median simple reaction time measure the speed at which 
the participant releases the press pad button in response 
to a stimulus. Reaction Time median simple movement 
time is the time, measured in milliseconds, taken to 
touch the stimulus after the press pad has been released 
in response to a single stimulus. This is a measurement 
of the motor speed and is sensitive for slowing. Reaction 
Time median 5-choice movement is the median of the 
measurement of speed with which the press pad button 
is released in response to a stimulus in any of 5 locations.
To demonstrate that the CANTAB-MCI does not 
change across a 3-month period as a result of repeated 
testing and without some neurologic event, we enrolled 
37 older adults who were not undergoing surgery to take 
the CANTAB-MCI at 3 time points (ie, baseline, 3-7 days, 
Figure 1.  CONSORT Diagram of Patient Flow Through the Study
Abbreviations: CONSORT, Consolidated Standards of Reporting Trials; MI, myocardial infarction; post-op, postoperative.
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and 3 months). They were of similar age, gender, educa-
tion level, income level, race-ethnicity, and marital status 
as the surgical groups. Their mean (SD) age was 60 (7) 
years, and 68% were female. Examination of their data 
revealed no changes across any of the time points in any 
components of the cognitive testing (data not shown).
• Protocol. The study was carried out after approval
was obtained from the appropriate university institutional 
review board, and after informed consent was received. 
After successful completion of the screening Motor 
Table 1.  Comparison of Baseline Characteristics Between Two Study Arms (N = 79)a
Abbreviations: BIS, Bispectral Index; PLIF, posterior lateral interbody fusion spine; SBP, systolic blood pressure.
aSome percentages do not total to 100 because of rounding.
Total BIS-guided Standard anesthesia 
Characteristic  (N = 79) anesthesia (n = 39)  (n = 40) P
Age, years, mean (SD) 59.1 (6.6) 59.6 (6.8) 58.5 (6.4) .456
Female sex, No. (%) 50 (63.3) 24 (61.5) 26 (65.0) .818
Race/ethnicity, No. (%) .550
White 73 (92.4) 35 (89.7)) 38 (95.0)
African American 4 (5.1) 2 (5.1) 2 (5.0)
Other 2 (2.6) 2 (5.1) 0 (0) 
Education, No. (%) .201
High school or some college 55 (69.6) 13 (33.3) 15 (37.5)
 College graduate or greater 24 (30.4) 26 (66.7) 25 (62.5)
Annual income, $, No. (%) .399
< 25,000 21 (26.6) 8 (20.5) 13 (32.5)
25,001-75,000 35 (44.3) 21 (53.8) 14 (35.0)
> 75,001 23 (29.1) 10 (25.6) 13 (32.5)
Currently married, No. (%) 54 (68.4) 28 (71.8) 26 (65.0) .630
Body mass index, kg/m2, mean (SD) 32 (8.1) 31.4 (7.6) 32.7 (8.6) .489
Anesthetic vapor, No. (%) .808
Sevoflurane 4 (5.1) 2 (5.1) 2 (5.0)
Desflurane 50 (63.3) 26 (66.7) 24 (60.0)
Isoflurane 25 (31.6) 11 (28.2) 14 (35.0)
Premedication, No. (%) .084
None 29 (36.7) 12 (30.8) 17 (42.5)
Midazolam 13 (16.5) 4 (10.3) 9 (22.5)
Opioid 37 (46.9) 23 (59.0) 14 (35.0)
Anesthesia time, h:min, mean (SD) 3:30 (0:58) 3:27 (0:57) 3:32 (0:59) .71
ASA physical status, No. (%) .823
2 37 (46.8) 19 (48.7) 18 (45.0)
 3 42 (36.5) 20 (51.3) 22 (55.0)
Baseline SBP, mm Hg, mean (SD) 134 (15.8) 133 (17.1) 136 (14.5) .387
Surgical procedure, No. (%) .394
Open abdominal 20 (25.3) 9 (23.1) 11 (27.5)
Laparoscopic/other  13 (16.5) 9 (23.1) 4 (10.0)
PLIF 31 (39.2) 13 (33.3) 7 (17.5)
Minimally invasive back 15 (19.2) 8 (20.5) 18 (45.0)
Medical history, No. (%)
Anxiety/depressive disorder 15 (17.4) 8 (18.2) 7 (16.7) > .999
Coronary artery disease 12 (14.0) 6 (13.6) 6 (14.3) > .999
Obstructive sleep apnea 20 (23.3) 13 (29.6) 7 (16.6) .36
Diabetes 22 (27.6) 11 (25.0) 11 (26.2) .82
Tobacco abuse, No. (%), N = 86 .701
None 41 (47.7) 20 (45.5) 21 (50.0)
Current/former abuse 45 (52.3) 24 (54.5) 21 (50.0)
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Screening Task, a full consent form was completed when 
the patient agreed to participate. The CANTAB-MCI 
battery was administered at baseline after consent was 
given (test time 1). A version of the battery was admin-
istered on postanesthetic days 3 to 5 (test time 2), in the 
patient’s hospital room, surgical clinic, or location con-
venient to the patient. Three to 5 days is an appropriate 
period that would ensure the drug half-lives have expired. 
The battery was again administered at 3 to 5 months (test 
time 3) at a location convenient to the patient. 
• Data Analysis. Data analysis included a descriptive 
summary, including means and standard deviations or 
frequency distributions, as appropriate. Comparisons of 
the groups at baseline was done using 2-sample t tests, χ2 
tests of association, or analysis of variance (ANOVA). 
To address the specific aim, we used a 2-way mixed 
design (ie, 1 within-subjects variable [time] and 1 
between-subjects variable [group]) repeated-measures 
ANOVA. Each of the assumptions of repeated-measures 
ANOVA (no significant outliers, the dependent variable 
is approximately normally distributed for each level of 
the independent variable, and sphericity) was tested. The 
only violation across the various dependent measures 
was violation of the sphericity assumption, which was 
managed with use of adjusted P values based on the 
Greenhouse-Geisser method. When a significant interac-
tion was found, post hoc testing was done. Additionally, 
a sensitivity analysis was performed using mixed model-
ing. Data analysis was conducted using SPSS version 22 
(IBM Corp); an α level of < .05 used throughout.
With an α level of .05 and 34 individuals in each 
group, the power of the repeated-measures ANOVA F 
test to detect a significant main effect or interaction was 
at least 80%, assuming that the ratio of group means to 
the standard deviation of the observations in the popula-
tions was at least 0.25. Cohen17 considers this a medium 
effect size. This power analysis was conservative because 
the methods used to estimate the repeated-measures 
models (namely mixed modeling) is robust with respect 
to missing data, as long as they are missing at random. 
Power analysis was conducted with sample size software 
(nQuery Advisor, v.6.02 Statsols).
Results
We screened patients from October 2014 through June 
2015, with the last follow-up completed in September 
2015. Of the 329 patients eligible for enrollment, 143 did 
not meet eligibility criteria and 98 chose not to partici-
pate (Figure 1). Of the 88 patients scheduled for surgery 
who were enrolled, 45 were randomly assigned to the 
BIS-guided anesthesia arm and 43 to the control arm of 
standard anesthesia care. There was no difference in the 
rate of withdrawal from the 2 surgical groups (P = .33). 
Patients who withdrew from the study were not signifi-
cantly different from patients who remained in the study 
on demographic or clinical characteristics measured at 
baseline, including time 1 CANTAB-MCI scores.
Demographic and clinical characteristics of patients 
by total sample and group assignment are summarized in 
Table 1. There were no significant differences between the 
2 groups on any demographic or clinical characteristic. 
• Anesthetic Vapor. Demonstrating the expected dif-
ference between the BIS-guided and standard anesthesia 
care groups, there were significant differences in mean 
concentration of inspired vapors between the groups 
(Table 2). The mean inspired concentrations of anesthe-
sia vapor were lower in the BIS-guided group.
• Safety. With regard to safety of the intervention, 
there were no adverse effects seen in either group in-
traoperatively. Satisfactory anesthesia was provided for 
every patient in both groups. There were no instances of 
operative recall in either group at 3 to 5 days or 3 to 5 
months postoperatively, even in the intervention group 
with age-adjusted MAC levels as low as 0.5.
• Effect of EEG-Guided Therapy vs Standard 
Anesthesia. The impact of the intervention on cognitive 
function was measured in 4 cognitive domains: memory 
(Delayed Matching to Sample percent correct), atten-
tion (Rapid Visual Information Processing A′ and Rapid 
Visual Information Processing median latency), visual 
memory (Paired Associates Learning total errors 6 shapes 
adjusted and Paired Associates Learning total errors ad-
justed), and speed of processing (Reaction Time mean 
and median simple reaction times, Reaction Time median 
simple movement time, and Reaction Time median 
5-choice movement). 
• Memory. There was no group by time interaction 
effect for the outcome Delayed Matching to Sample 
percent correct, demonstrating that memory scores across 
time were not different between the groups (Table 3). 
• Attention. For both indicators of this domain, Rapid 
Visual Information Processing A′ (P = .58) and Rapid 
Table 2.  Mean Concentration of Inspired and Expired Vapor Used During Anesthesia Compared Between 
Intervention and Control (Standard Anesthesia) Groups
 Inspired concentration, mean (SD) Expired concentration, mean (SD)
Anesthetic vapor  Intervention Control P  Intervention Control P
Sevoflurane 1.8 (0.12) 2.5 (0.35) .025 1.5 (0.35) 2.0 (0.20) .36
Desflurane 4.4 (0.84) 6.1 (1.0) < 0.001 3.8 (0.63) 5.6 (1.9) .008
Isoflurane 1.5 (0.86) 1.9 (0.37) < 0.001 1.1 (0.78) 1.2 (0.19) .25
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Visual Information Processing median latency (P = .55), 
there was no group by time interaction (see Table 3). 
• Short-Term/Visual Memory Domain. There was a sig-
nificant group by time interaction in the overall test for 
both indicators, Paired Associates Learning total errors 6 
shapes adjusted (P = .02) and Paired Associates Learning 
total errors adjusted (P = .02), of this domain (see Table 3). 
Post hoc testing revealed that with regard to the Paired 
Associates Learning total errors 6 shapes adjusted, the 
scores between the 2 groups were similar at baseline (P = 
.75), but the trajectory across time diverged at time 2 (P 
= .019) in that the BIS-guided group had better (lower) 
scores than did the standard anesthesia care group (Figure 
2) after surgery. In the BIS-guided group, there was a sig-
nificant improvement in scores between times 1 and 2 (P
= .016) and between times 1 and 3 (P = .001). At time 3,
there were no differences between groups (P = .32).
In regard to Paired Associates Learning total errors 
adjusted, post hoc testing revealed that the scores between 
the 2 groups were similar at baseline (P = .76) and at time 
2 (P = .21). At time 3, the groups diverged (P = .01), with 
the BIS-guided group having better (lower) scores than the 
standard anesthesia care group had. The BIS-guided group 
demonstrated a significant improvement in scores between 
times 1 and 2 (P = .01) and times 2 and 3 (P = .07).
• Speed of Processing/Latency. The indicator Reaction







Overall P value 
interaction  
of group by 
time
Memory (nonverbalizable/patterns)
  DMS percent Baseline 85.6 (10.0) 81.7 (11.5)
  correct Time 2 83.1 (12.6) 78.3 (16.7) .74
Time 3 82.7 (12.0) 80.3 (13.1)
Memory (short-term/visual)
  PAL total errors Baseline 39.4 (34.4) 41.6 (32.1)
  adjusted Time 2 34.7 (29.6) 57.4 (43.7) .02
Time 3 25.7 (21.8) 33.2 (30.5)
  PAL total errors Baseline 12 (10.1) 11.3 (9.6)
  6 shapes Time 2 7.5 (9.9) 13.6 (12.5) .02
  adjusted Time 3 6.6 (5.9) 8.3 (9.3)
Attention (visual sustained)
  RVP A´ Baseline 0.88 (0.05) 0.87 (0.06)
Time 2 0.87 (0.06) 0.85 (0.07) .58
Time 3 0.89 (0.05) 0.89 (0.06)
  RVP median Baseline 444.1 (114.6) 451.8 (150.1)
  latency Time 2 498.3 (179.0) 518.8 (218.3) .55
Time 3 457.4 (150.8) 439.5 (137.7)
Processing speed/ latency
  RTI mean simple Baseline 347.4 (103.7) 349.6 (92.7)
  Reaction Time Time 2 390 (88.4) 438.6 (117.7) .03
Time 3 362 (121.5) 343.5 (67.5)
  RTI median Baseline 309.3 (54.7) 316.4 (59.1)
  simple Reaction Time 2 355.7 (61.6) 394 (84.4) .07
 Time Time 3 312.6 (56.1) 319 (51.4)
  RTI median Baseline 590.9 (332.4) 522.3 (130.8)
  simple Time 2 576.3 (145.2) 615.7 (216.4) .15
  movement time Time 3 494.9 (86.9) 485.7 (97.4)
  RTI median 5- Baseline 545.4 (202.9) 507.6 (118.4)
  choice Time 2 567.7 (144.6) 640.4 (266.5) .06
  movement Time 3 486.1 (84.7) 474.1 (94.0)
Table 3.  Neurocognitive Function Scores Between Two Surgical Groups Across Time
Abbreviations: BIS, Bispectral Index; DMS, Delayed Matching to Sample; PAL, Paired Associates Learning; RTI, Reaction Time; RVP, 
Rapid Visual Information Processing.
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Time mean simple reaction time demonstrated a sig-
nificant group by time interaction (P = .03). None of the 
other indicators were found to have significant group 
by time interactions (see Table 3). Regarding these 3, 
Reaction Time median simple reaction time (P = .07), 
Reaction Time median simple movement time (P = .15), 
and Reaction Time median 5-choice movement time (P = 
.06), there were no group by time interactions (see Table 
3). There was a main effect of time for all 4 (P < .001, P < 
.001, P = .001, and P < .001, respectively).
Post hoc testing revealed that in regard to the Reaction 
Time mean simple reaction time, the scores between the 
2 groups were similar at baseline (P = .92), but the trajec-
tory across time diverged at time 2 (P = .04) in that the 
BIS-guided group had better (lower) scores vs the stan-
dard anesthesia care group. At time 3, there were again 
no differences between groups (P = .4).
Mixed modeling was used to perform a sensitivity 
analysis. Our findings were unchanged.
Discussion
We examined the impact of BIS-guided anesthesia on 
cognitive outcomes using a state-of-the art neurocogni-
tive testing computerized platform and, unlike others, 
we tested specific cognitive domains. We demonstrated 
significantly lower volatile anesthesia exposure in the in-
tervention group (BIS-guided anesthesia) compared with 
the standard anesthesia care group. We demonstrated the 
safety of the intervention in that there were no adverse 
events associated with its use. We also demonstrated cog-
nitive decline in the visual memory domain in the stan-
dard anesthesia care group vs BIS-guided anesthesia group 
in the 3- to 5-day postsurgery period compared with base-
line, but not at the 3- to 5-month period. This reflects that 
POCD occurs in specific domains but may be time limited, 
reflecting the findings of some previous studies.3,4 
Reflecting the main effect of time seen in the regres-
sion analyses with both the 2 surgical groups alone, 
and the 3 group analyses, both surgical groups demon-
strated postoperative depression in cognitive function in 
every outcome measure (with the exception of Delayed 
Matching to Sample), but in every instance, the standard 
anesthesia care group’s was more pronounced. These 
findings indicate there is a higher cognitive obstacle in 
the memory domains encountered by patients exposed 
to a higher cumulative dose of volatile anesthetic. The 
outcome measures Paired Associates Learning total errors 
adjusted and Paired Associates Learning total errors 6 
shapes adjusted were both found to be statistically signif-
icant. The Paired Associates Learning component of the 
CANTAB-MCI battery reflects the greatest impairment 
and severity of dysfunction in MCI and AD.18 The finding 
of Paired Associates Learning total errors adjusted is of 
greatest concern because of a close relationship with am-
nestic MCI.19 Hippocampal atrophy and loss of function 
is a known pattern beginning in MCI and advancing in 
AD. The recall of objects in space is a process involving 
the hippocampus directly tested in the Paired Associates 
Learning.20 Junkkila and colleagues19 found that the 
Paired Associates Learning total errors adjusted variable 
accounted for the largest difference between amnestic 
MCI and mild AD. This outcome measure reflects a sig-
nificant cognitive decline in the visual memory domain. 
The association of these findings and the known neu-
ropathologic inflammatory sequel of these anesthetics 
suggest these volatile anesthetics are not benign.
The memory impairments noted in our study with 
the use of standard anesthesia not guided by EEG have 
the potential to adversely influence patient discharge. If 
patients have memory impairments, they will be unable 
to adequately process and remember important discharge 
instructions. Even when instructions are written, they 
are very commonly standard instructions that lack the 
specificity and detail needed for each individual patient. 
Patients and family members have substantial difficulty 
remembering instructions even under ideal situations,21 
and our results suggest that most middle-aged and older 
postoperative patients have enough POCD to impair their 
ability to retain the information needed for successful 
discharge and recovery.
Our findings differ from two of the most recent studies 
investigating use of derived EEG guidance as a means to 
reduce the incidence of POCD. A large German study led 
by Radtke et al22 failed to find a significant difference 
in POCD between derived EEG guidance and standard 
anesthesia care at day 7 (P = .372) nor day 90 (P = .062). 
Our study differs in that we used volatile anesthetics 
exclusively for maintenance, rather than introducing 
macromolar anesthetics (propofol), which could be con-
sidered a confounder. Other differentiation between the 
studies was that we used the complete CANTAB-MCI 
battery and examined differences in specific domains that 
Figure 2. Paired Associates Learning (PAL) Total Errors 
6 Shapes Adjusted Across Time by Group
Abbreviations: ANOVA, analysis of variance; BIS, Bispectral 
Index; early post-anesthesia, 3-5 days after anesthesia; late post-
anesthesia, 3-5 months after anesthesia.
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we explicated a priori. Previous investigators who used 
the CANTAB-MCI reported cognitive function as a global 
phenomenon (despite the fact that the CANTAB-MCI has 
no such measures), failing to take advantage of the preci-
sion offered by assessing cognitive function in domains. 
The CANTAB-MCI battery was designed for sensitivity in 
MCI, which shares affected domains with POCD. Radtke 
and colleagues used 3 CANTAB pretests of pattern recog-
nition memory, spatial recognition memory, and choice 
reaction time. Pattern recognition memory and spatial 
recognition memory are designed to help prepare for the 
more robust Paired Associates Learning test. The remain-
der of their battery consisted of tests administered orally 
(a visual-verbal learning test and the Stroop Color-Word 
Test).22 Although the number of patients in their study 
was respectable (n = 1,155), the differences in methods 
could easily account for the different findings.
The second of the derived EEG guidance studies 
before ours, by Chan et al,12 found higher levels of POCD 
at 3 months (P = .02) rather than 1 week (P = .06), oppo-
site to the findings of our study and much of the previous 
literature. Although the findings are similar in that BIS-
monitored care demonstrates less POCD, the dramatic 
difference in early vs late findings could be related to the 
neurocognitive battery used in the trial by Chan et al. In 
addition, similar to Radtke and associates,22 there were 
a number of patients (n = 99, 11%) who received mac-
romolar anesthetic maintenance (propofol), presenting 
confounders.
Although our study had the strength of being a ran-
domized controlled study, it has limitations. The primary 
limitation was the smaller sample size, which limited our 
ability to determine any heterogeneity of treatment effect 
because we could not perform subgroup analyses.
Nevertheless, our study represents the first use of the 
complete CANTAB-MCI battery in a study of POCD. The 
CANTAB-MCI was developed and tested in populations 
with MCI. Our study demonstrates that the CANTAB-
MCI is sensitive enough to detect cognitive changes in 
the surgical anesthetic population. The study has dem-
onstrated ease-of-use and no burden for users in the 
perioperative environment. The BIS monitor allowed for 
anesthetic titration to low levels without experiencing 
an episode of recall. This study provides empirical evi-
dence to support previous authors’ recommendations of 
BIS-guided titration as effective for POCD, especially in 
individuals over 60 years of age.23 
Conclusion
This study provides important data on patient neuro-
cognitive outcomes that will assist anesthesia providers 
to make evidence-based decisions about the optimal 
anesthetic techniques to promote best patient outcomes. 
Careful titration, as guided by the BIS monitor, by ex-
perienced anesthetic providers can lead to a measurable 
improvement in patient outcomes. Taken in concert with 
previous findings, our results suggest that BIS-guided 
anesthesia is safe, results in lower total overall volatile 
anesthetic exposure, and leads to fewer disturbances in 
cognitive function; thus, BIS-guided anesthesia should 
be considered by more providers as the standard of care.
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